Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
3 pending office actions • 2 art units • 3 examiners • 0 of 3 (0%) have an AI response strategy ready
Cap Diagnostics LLC Dba Pathnostics has 3 pending office actions in the Biotechnology & Pharmaceuticals technology area. These actions are being reviewed by 3 distinct examiners, meaning each pending application is under the supervision of a different individual. The portfolio is spread across 2 distinct art units, which indicates technical diversity within the biotechnology sector. This distribution suggests that the company is pursuing distinct diagnostic or pharmaceutical paths simultaneously.
FERNANDEZ, SUSAN EMILY is the busiest examiner for this company, with 1 pending office action. This confirms that the pending office actions are distributed among the examiners. Prosecution strategy should account for the specific tendencies of these examiners while noting that the 2 distinct art units may share common procedural or technical standards. The limited number of pending actions suggests a focused but diverse approach to securing intellectual property in the pharmaceutical space. With the examiners involved, the applicant must prepare for unique sets of feedback and examination styles.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (33%) |
| §103 only | 1 (33%) |
| Multi-statute (no §101) | 1 (33%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| FERNANDEZ, SUSAN EMILY | 1 | 52.5% | +60.8% |
| HAQ, SHAFIQUL | 1 | 64.8% | +55.2% |
| SPANGLER, JOSEPH RANKIN | 1 | 41.2% | +69.5% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18824184 | METHODS FOR TREATING POLYMICROBIAL INFECTIONS | FERNANDEZ, SUSAN EMILY | — |
| 18669370 | METHODS AND SYSTEMS FOR DETECTING URINARY TRACT INFECTIONS | HAQ, SHAFIQUL | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17830227 | METHODS AND SYSTEMS FOR PREPARING THERAPEUTIC SOLUTIONS FOR POLYMICROBIAL INFECTIONS | SPANGLER, JOSEPH RANKIN | 14d |
| 18824184 | METHODS FOR TREATING POLYMICROBIAL INFECTIONS | FERNANDEZ, SUSAN EMILY | — |
| 18669370 | METHODS AND SYSTEMS FOR DETECTING URINARY TRACT INFECTIONS | HAQ, SHAFIQUL | — |
| Art Unit | Apps |
|---|---|
| 1651 | 1 |
| 1656 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18824184 | METHODS FOR TREATING POLYMICROBIAL INFECTIONS | FERNANDEZ, SUSAN EMILY | 1651 | §102§103 | Non-Final OA | — | Pending | Sep 04, 2024 |
| 18669370 | METHODS AND SYSTEMS FOR DETECTING URINARY TRACT INFECTIONS | HAQ, SHAFIQUL | — | §101§103 | Non-Final OA | — | Pending | May 20, 2024 |
| 17830227 | METHODS AND SYSTEMS FOR PREPARING THERAPEUTIC SOLUTIONS FOR POLYMICROBIAL INFECTIONS | SPANGLER, JOSEPH RANKIN | 1656 | §103 | Non-Final OA | 14d | Pending | Jun 01, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial